# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Stifel analyst Benjamin Burnett maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and raises the price target from $63 t...
Citigroup analyst Yigal Nochomovitz maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and lowers the price target from $...
JP Morgan analyst Anupam Rama maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Overweight and lowers the price target from ...
RBC Capital analyst Gregory Renza reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and maintains $61 price target.
Wedbush analyst Robert Driscoll reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and maintains $54 price target.
Oppenheimer analyst Matthew Biegler maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and lowers the price target...